Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
J Pharmacol Sci ; 151(4): 187-194, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36925217

ABSTRACT

Allyl isothiocyanate (AITC) activates transient receptor potential ankyrin 1 (TRPA1) channel, which is involved in the control of intestinal mucosal blood flow. However, the mechanism underlying the increased gastric mucosal blood flow (GMBF) in response to AITC remains unknown. We examined the effect of AITC on GMBF in the ex vivo stomachs of normal and sensory deafferented rats using a laser Doppler flowmeter. Mucosal application of AITC increased GMBF in a concentration-dependent manner. Repeated AITC exposure resulted in a marked desensitization. The increased GMBF response induced by AITC was entirely blocked by co-application of TRPA1 channel blockers HC-030031 or AP-18. Increased GMBF in response to AITC was significantly attenuated by chemical deafferentation following systemic capsaicin injections (total dose: 100 mg/kg). In contrast, increased GMBF responses to capsaicin, a transient receptor potential vanilloid 1 (TRPV1) activator, were completely abolished by chemical deafferentation. The increased GMBF response to AITC was markedly inhibited by BIBN 4096, a calcitonin gene-related peptide receptor (CGRP) antagonist, or AGP-8412, an adrenomedullin receptor antagonist. These results suggest that AITC-stimulated TRPA1 activation results in the increased GMBF through the release of CGRP and adrenomedullin.


Subject(s)
Calcitonin Gene-Related Peptide , Transient Receptor Potential Channels , Rats , Animals , Calcitonin Gene-Related Peptide/metabolism , Capsaicin/pharmacology , Adrenomedullin , TRPA1 Cation Channel , Isothiocyanates/pharmacology
2.
J Pharmacol Sci ; 145(1): 122-129, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33357770

ABSTRACT

Functional dyspepsia (FD) is thought to be mainly based on gastric motility dysfunction and chronic hypersensitivity, yet FD animal models has been reported a few. We studied to establish the mouse model of impaired gastric motility induced by a pungent ingredient of wasabi allyl isothiocyanate (AITC), which is reliable to evaluate prokinetic agents. Male ddY mice were used. Gastric motility was measured by 13C-acetic acid breath test in conscious mice. AITC (80 mM) was given 60 min before the measurement of motility. Prokinetic agents including itopride (30, 100 mg/kg), mosapride (0.1-1 mg/kg), neostigmine (30 µg/kg), acotiamide (10-100 mg/kg), and daikenchuto (100-1000 mg/kg) were given 40 min before the measurement. AITC impaired gastric motility without mucosal damages, which reverted 24 h after AITC treatment. The decreased motility induced by AITC was restored by prokinetic agents such as itopride, mosapride, neostigmine, and acotiamide. In separate experiment, daikenchuto recovered the decreased motility induced by AITC, although daikenchuto had no effect on motility in normal condition. In conclusion, it is considered that the AITC-induced impaired gastric motility mouse model is useful to develop new prokinetic agents for treatment of FD, and to re-evaluate traditional Japanese herbal medicines.


Subject(s)
Benzamides/administration & dosage , Benzyl Compounds/administration & dosage , Dyspepsia/drug therapy , Gastrointestinal Motility , Isothiocyanates/adverse effects , Morpholines/administration & dosage , Neostigmine/administration & dosage , Phytotherapy , Plant Extracts/administration & dosage , Thiazoles/administration & dosage , Wasabia/chemistry , Animals , Benzamides/pharmacology , Benzyl Compounds/pharmacology , Disease Models, Animal , Dyspepsia/physiopathology , Gastrointestinal Motility/drug effects , Isothiocyanates/isolation & purification , Male , Mice, Inbred Strains , Morpholines/pharmacology , Neostigmine/pharmacology , Panax , Plant Extracts/pharmacology , Thiazoles/pharmacology , Zanthoxylum , Zingiberaceae
3.
Yakugaku Zasshi ; 138(8): 1003-1009, 2018.
Article in Japanese | MEDLINE | ID: mdl-30068839

ABSTRACT

Capsaicin is a constituent of chili pepper, and induces the burning sensation on the tongue. The site of action for capsaicin has been discovered as transient receptor potential vanilloid receptor subtype 1 (TRPV1) that resides on the membranes of pain- and heat-sensing primary afferent nerves. The immunohistochemical study on the stomach revealed that nerve fibers expressing TRPV1 exist along gastric glands in the mucosa, around blood vessels in the submucosa, in the myenteric plexus, and in the smooth muscle layers. High numbers of TRPV1-immunoreactive axons were observed in the rectum and distal colon. Therefore, capsaicin stimulates TRPV1 not only on the tongue but also in the gut. In this review, the mechanism of gastrointestinal mucosal defense enhanced by capsaicin was summarized. TRPV1 plays a protective role in gastrointestinal mucosal defensive mechanism. Hypersensitivity of afferent fibers occurs during gastrointestinal inflammation. Abnormalities of primary afferent nerve fibers are strongly associated with the visceral hypersensitive state in inflammatory bowel disease (IBD). The alteration of TRPV1 channels in mucosa contributes to the visceral hypersensitivity in colitis model mice. TRPV1-expressing neurons in the gut are thought to be extrinsic sensory afferent neurons that operate to maintain gastrointestinal functions under physiological and inflammatory states.


Subject(s)
Capsaicin , Spices , TRPV Cation Channels/metabolism , TRPV Cation Channels/physiology , Animals , Capsaicin/administration & dosage , Capsaicin/adverse effects , Capsaicin/pharmacology , Colitis/metabolism , Gastric Mucosa/innervation , Guinea Pigs , Humans , Intestinal Mucosa/innervation , Mice , Nerve Fibers/metabolism , Neurons, Afferent/metabolism , Rats , Sensory Receptor Cells/metabolism , Spices/adverse effects
4.
Exp Neurol ; 285(Pt A): 41-50, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27616276

ABSTRACT

Transient receptor potential melastatin 2 (TRPM2) is a thermosensitive, Ca2+-permeable cation channel. TRPM2 contributes to the pathogenesis of inflammatory bowel disease, and inflammatory and neuropathic pain. We hypothesized that TRPM2 is important for visceral nociception and the development of visceral hypersensitivity. Therefore, we investigated the expression of TRPM2 channels and their involvement in visceral nociception in normal physiology and under pathological conditions that cause visceral hypersensitivity in rats. TRPM2 immunoreactivities were detected in the mucosa and muscle layer of the rat gastrointestinal tract. TRPM2 immunopositive cell bodies were almost completely co-localized with calretinin- and NeuN-positive cells in the myenteric plexus. We found that the majority of the TRPM2-immunoreactive cells were double-labeled with the retrograde marker fluorogold in lumbar 6/sacral 1 dorsal root ganglia (DRG), indicating that TRPM2 is expressed in spinal primary afferents innervating the distal colon. Subtypes of TRPM2-immunopositive DRG neurons were labeled by the A-fiber marker NF200, the C-fiber marker IB4, substance P, calcitonin gene-related peptide, or P2X3 receptor. We found that oral administration of the TRPM2 inhibitor econazole (30mg/kg) reduced the visceromotor response (VMR) to noxious colorectal distention (CRD) at 80mmHg in control rats. Expression of TRPM2 in the mucosa of the distal colon was increased in a trinitrobenzene sulfonic acid-induced colitis model. The VMR to CRD significantly increased in colitis model rats compared with control rats at 40, 60, and 80mmHg. Econazole restored visceral hypersensitivity to the control level. Furthermore, TRPM2-deficient mice showed significantly attenuated trinitrobenzene sulfonic acid induced visceral hypersensitivity compared with wild-type mice. In conclusion, TRPM2 channels contribute to visceral nociception in response to noxious stimuli under normal conditions and visceral hypersensitivity in pathological conditions.


Subject(s)
Hypersensitivity/metabolism , TRPM Cation Channels/metabolism , Visceral Pain/metabolism , Animals , Antigens, CD/metabolism , Calbindin 2/metabolism , Calcium-Binding Proteins , Colitis/chemically induced , Colitis/complications , Colon/innervation , Dextrans/pharmacokinetics , Disease Models, Animal , Electromyography , Evoked Potentials, Motor/drug effects , Evoked Potentials, Motor/physiology , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescein-5-isothiocyanate/pharmacokinetics , Ganglia, Spinal/cytology , Gastrointestinal Tract/innervation , Gastrointestinal Tract/metabolism , Hypersensitivity/genetics , Integrin alpha Chains/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microfilament Proteins , Nerve Tissue Proteins/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2X/metabolism , Stilbamidines/pharmacokinetics , Substance P/metabolism , TRPM Cation Channels/genetics , Trinitrobenzenesulfonic Acid/toxicity , Visceral Pain/etiology , Visceral Pain/genetics
5.
Eur J Pharmacol ; 771: 220-8, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26712376

ABSTRACT

Constipation is the most common side effect of morphine. Morphine acts centrally and on peripheral sites within the enteric nervous system. There are a few comprehensive studies on morphine-induced constipation in the small and large intestine by the activation of central and peripheral µ-opioid receptors. We investigated the differences in the inhibition of the small and large intestinal transit in normal and morphine-tolerant mice. Morphine reduced the geometric center in the fluorescein isothiocyanate-dextran assay and prolonged the bead expulsion time in a dose-dependent manner. The inhibitory effects of morphine were blocked by µ-opioid antagonist ß-funaltrexamine, but not by δ- and κ-opioid antagonists. The peripheral opioid receptor antagonist, naloxone methiodide, partially blocked morphine's effect in the small intestine and completely blocked its effect in the large intestine. The intracerebroventricular administration of naloxone significantly reversed the delay of small intestinal transit but did not affect morphine-induced inhibition of large intestinal transit. Naloxone methiodide completely reversed the inhibition of large intestinal transit in normal and morphine-tolerant mice. Naloxone methiodide partially reversed the morphine-induced inhibition of small intestinal transit in normal mice but completely reversed the effects of morphine in tolerant mice. Chronic treatment with morphine results in tolerance to its inhibitory effect on field-stimulated contraction in the isolated small intestine but not in the large intestine. These results suggest that peripheral and central opioid receptors are involved in morphine-induced constipation in the small and large intestine during the early stage of treatment, but the peripheral receptors mainly regulate constipation during long-term morphine treatment.


Subject(s)
Analgesics, Opioid/pharmacology , Gastrointestinal Transit/drug effects , Intestine, Large/drug effects , Intestine, Small/drug effects , Morphine/pharmacology , Receptors, Opioid, mu/drug effects , Animals , Central Nervous System/drug effects , Dose-Response Relationship, Drug , Injections, Intraventricular , Male , Mice , Naloxone/pharmacology , Naltrexone/analogs & derivatives , Naltrexone/pharmacology , Narcotic Antagonists/pharmacology , Peripheral Nervous System/drug effects , Receptors, Opioid, mu/antagonists & inhibitors
6.
Histochem Cell Biol ; 142(6): 635-44, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25002127

ABSTRACT

Transient receptor potential cation channel subfamily V member 1 (TRPV1) plays a role in esophageal function. However, the distribution of TRPV1 nerve fibers in the esophagus is currently not well understood. In the present study, we investigated the distribution of TRPV1 and neurotransmitters released from TRPV1 nerve fibers in the mouse lower esophagus. Furthermore, we investigated changes in the presence of TRPV1 in the mouse model of esophagitis. Numerous TRPV1-immunoreactive nerve fibers were seen in both the submucosal layer and myenteric plexus of the lower esophagus and colocalized with calcitonin gene-related peptide (CGRP). TRPV1 colocalized with substance P in axons in the submucosal layer and myenteric plexus. TRPV1 colocalized with neuronal nitric oxide synthase in the myenteric plexus. We observed some colocalization of CGRP with the vesicular acetylcholine (ACh) transporter, packaging of ACh into synaptic vesicles after its synthesis in terminal cytoplasm, in the submucosal layer and myenteric plexus. In the esophagitis model, the number of the TRPV1 nerve fibers did not change, but their immunoreactive intensity increased compared with sham-operated mice. Inhibitory effect of exogenous capsaicin on electrically stimulated twitch contraction significantly increased in esophagitis model compared with the effect in sham-operated mice. Overall, these results suggest that TRPV1 nerve fibers projecting to both the submucosal and muscle layer of the esophagus are extrinsic spinal and vagal afferent neurons. Furthermore, TRPV1 nerve fibers contain CGRP, substance P, nitric oxide, and ACh. Therefore, acid influx-mediated TRPV1 activation may play a role in regulating esophageal relaxation.


Subject(s)
Esophagus/metabolism , Nerve Fibers/metabolism , TRPV Cation Channels/metabolism , Animals , Capsaicin/pharmacology , Disease Models, Animal , Esophagitis, Peptic/physiopathology , Esophagus/cytology , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Muscle Contraction/drug effects , Nitric Oxide Synthase/metabolism , Sensory System Agents/pharmacology , TRPV Cation Channels/chemistry
7.
J Pharmacol Exp Ther ; 348(3): 383-92, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24345467

ABSTRACT

(E)-Methyl 2-((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (7-hydroxymitragynine), a main active constituent of the traditional herbal medicine Mitragyna speciosa, is an indole alkaloid that is structurally different from morphine. 7-Hydroxymitragynine induces a potent antinociceptive effect on mouse acute pain through µ-opioid receptors. In this study, we developed dual-acting µ- and δ-opioid agonists MGM-15 and MGM-16 from 7-hydroxymitragynine for the treatment of acute and chronic pain. MGM-16 showed a higher potency than that of 7-hydroxymitragynine and MGM-15 in in vitro and in vivo assays. MGM-16 exhibited a high affinity for µ- and δ-opioid receptors, with K(i) values of 2.1 and 7.0 nM, respectively. MGM-16 showed µ- and δ-opioid full agonistic effects in a guanosine 5'-O-(3-[(35)S]thiotriphosphate) binding assay and in a functional test using electrically elicited guinea pig ileum and mouse vas deferens contractions. Systemic administration of MGM-16 produced antinociceptive effects in a mouse acute pain model and antiallodynic effects in a chronic pain model. The antinociceptive effect of MGM-16 was approximately 240 times more potent than that of morphine in a mouse tail-flick test, and its antiallodynic effect was approximately 100 times more potent than that of gabapentin in partial sciatic nerve-ligated mice, especially with oral administration. The antinociceptive effect of MGM-16 was completely and partially blocked by the µ-selective antagonist ß-funaltrexamine hydrochloride (ß-FNA) and by the δ-selective antagonist naltrindole, respectively, in a tail-flick test. The antiallodynic effect of MGM-16 was completely blocked by ß-FNA and naltrindole in a neuropathic pain model. These findings suggest that MGM-16 could become a class of a compound with potential therapeutic utility for treating neuropathic pain.


Subject(s)
Hyperalgesia/drug therapy , Neuralgia/drug therapy , Receptors, Opioid, delta/agonists , Receptors, Opioid, mu/agonists , Secologanin Tryptamine Alkaloids/pharmacology , Administration, Oral , Animals , CHO Cells , Cricetinae , Cricetulus , Hyperalgesia/physiopathology , Ileum/drug effects , Ileum/physiopathology , Injections, Subcutaneous , Male , Mice , Muscle Contraction , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Neuralgia/physiopathology , Physical Stimulation , Rabbits , Radioligand Assay , Receptors, Opioid, delta/antagonists & inhibitors , Receptors, Opioid, mu/antagonists & inhibitors , Sciatic Neuropathy/drug therapy , Sciatic Neuropathy/physiopathology , Secologanin Tryptamine Alkaloids/chemistry , Secologanin Tryptamine Alkaloids/therapeutic use , Stereoisomerism , Touch , Vas Deferens/drug effects , Vas Deferens/physiopathology
8.
Eur J Pharmacol ; 718(1-3): 314-22, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-24012929

ABSTRACT

Various events including digestion and inflammation are regulated by secreted phospholipase A2 (sPLA2) in gastrointestinal tissues, however, the role of sPLA2 on contractile activity has not been elucidated. We investigated the effect of bee venom PLA2 (bvPLA2), which is homologous to the central domain of group III sPLA2, on contractile activity in mouse rectum. The longitudinal preparations of rectum showed rhythmic phasic contractions (RPCs) with varied amplitude and high frequency. Treatment with bvPLA2 at 1 µg/ml increased amplitudes of RPCs without marked changes in frequency and basal tone. RPCs by bvPLA2 were affected neither by atropine nor by inhibition of nitric oxide synthase, and partly inhibited by dual inhibition of the cyclooxygenase and lipoxygenase pathways. Pretreatment of bvPLA2 with dithiothreitol, which inhibits the enzyme activity, partly reduced bvPLA2-induced RPCs, and arachidonic acid-increased RPCs were completely abolished by cyclooxygenase/lipoxygenase inhibition. Phasic contractions have been shown to be regulated by gap junction and to be decreased in gastrointestinal tissues with experimental colitis. Treatment with inhibitors of gap junction proteins, 50 µM 18ß-glycyrrhetinic acid and 100 µM carbenoxolone, partly and almost completely reduced bvPLA2-induced RPCs without and with the cyclooxygenase/lipoxygenase inhibitors, respectively, but not arachidonic acid-induced RPCs. In rectum from mouse having colitis, where total levels and modified forms of connexin43 increased, bvPLA2-induced RPCs were markedly decreased. Our results suggest that both arachidonic acid metabolism and gap junction proteins independently regulated the sPLA2-induced RPCs in mouse rectum. An increased expression and/or modification of connexin43 may influence sPLA2-induced RPCs in rectum with colitis.


Subject(s)
Bee Venoms/enzymology , Colitis/physiopathology , Connexin 43/metabolism , Eicosanoids/metabolism , Muscle Contraction/drug effects , Phospholipases A2/pharmacology , Rectum/drug effects , Animals , Bethanechol/pharmacology , Carbenoxolone/pharmacology , Colitis/metabolism , Connexin 43/antagonists & inhibitors , Dextran Sulfate/pharmacology , Glycyrrhetinic Acid/analogs & derivatives , Glycyrrhetinic Acid/pharmacology , In Vitro Techniques , Male , Mice , Rectum/metabolism , Rectum/physiology
9.
Pharmacology ; 92(1-2): 60-70, 2013.
Article in English | MEDLINE | ID: mdl-23920479

ABSTRACT

BACKGROUND AND AIMS: Activation of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin leads to gastric hyperemic response through capsaicin-sensitive sensory nerves and nitric oxide (NO). The aim of the present study is to examine which isoform of nitric oxide synthase (NOS)/NO is involved in the hyperemic response to capsaicin in the rat stomach. METHODS: Gastric mucosal blood flow (GMBF) was measured by laser Doppler flowmetry in rats. The localizations of TRPV1 and neuronal NOS (nNOS) in the rat gastric mucosa were detected by immunohistochemical staining. RESULTS: The nNOS inhibitor N(5)-[imino(propylamino)methyl]-L-ornithine substantially reduced GMBF during capsaicin application, whereas the endothelial NOS (eNOS) inhibitor N(5)-(1-iminomethyl)-L-ornithine did not affect the effect of capsaicin during the application. The nonselective NOS inhibitor N(G)-nitro-L-arginine methyl ester apparently inhibited the capsaicin-induced GMBF, while the inducible NOS inhibitor 1400W did not affect GMBF response to capsaicin. The immunohistochemical studies revealed nerve fibers coexpressing TRPV1 and nNOS around blood vessels in the gastric submucosa. CONCLUSION: We demonstrated for the first time that nNOS/NO is involved in gastric hyperemic responses to capsaicin.


Subject(s)
Gastric Mucosa/metabolism , Hyperemia/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide/metabolism , Animals , Capsaicin , Colon/drug effects , Colon/physiology , Enzyme Inhibitors/pharmacology , Gastric Mucosa/blood supply , Gastric Mucosa/drug effects , Gastric Mucosa/innervation , Hyperemia/chemically induced , Hyperemia/physiopathology , In Vitro Techniques , Male , Mice , Muscle Contraction/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Ornithine/analogs & derivatives , Ornithine/pharmacology , Rats , Rats, Sprague-Dawley , TRPV Cation Channels/metabolism
10.
Dig Dis Sci ; 58(12): 3440-51, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23695873

ABSTRACT

BACKGROUND AND OBJECTIVE: Although 5-fluorouracil (5-FU) is a widely used as chemotherapy agent, severe mucositis develops in approximately 80% of patients. 5-FU-induced small intestinal mucositis can cause nausea and vomiting. The current study was designed to investigate peripheral alterations due to the 5-FU-induced mucositis of neuronal and non-neuronal 5-HT3 and NK1 receptor expression by immunohistochemical analysis. METHODS: 5-FU was administered by i.p. injection to C57BL/6 mice. After 4 days, segments of the jejunum were removed. The specimens were analyzed by immunohistochemistry, real-time PCR, and enzyme immunoassay. RESULTS: The numbers of 5-HT3 receptor immunopositive cells and nerve fibers in mucosa were increased by 5-FU treatment. The 5-HT3 receptor immunopositive cell bodies were found only in jejunal submucosa and myenteric plexus in the 5-FU-treated mice. The numbers of NK1 receptor cells in mucosa and immunopositive expression of NK1 receptors in deep muscular plexus were dramatically increased in 5-FU-treated mice. Real-time PCR demonstrated that 5-FU treatment significantly increased mRNA levels of 5-HT3A, 5-HT3B, and NK1 receptors. The amounts of 5-HT and substance P increased after 5-FU treatment. The 5-HT3 or NK1 receptor immunopositive cells colocalized with both 5-HT and substance P. Furthermore, 5-HT3 and NK1 receptors colocalized with CD11b. CONCLUSIONS: The 5-HT3 and NK1 immunopositive macrophages and mucosal mast cells in lamina propria release 5-HT and substance P, which in turn activate their corresponding receptors on mucosal cells in autocrine and paracrine manners. It is assumed to result in the release of 5-HT and substance P in mucosa.


Subject(s)
Fluorouracil/adverse effects , Jejunal Diseases/metabolism , Mucositis/metabolism , Receptors, Neurokinin-1/biosynthesis , Receptors, Serotonin, 5-HT3/biosynthesis , Animals , Autocrine Communication , Disease Models, Animal , Jejunal Diseases/chemically induced , Jejunal Diseases/pathology , Macrophages/metabolism , Macrophages/pathology , Male , Mast Cells/metabolism , Mast Cells/pathology , Mice , Mice, Inbred C57BL , Mucositis/chemically induced , Mucositis/pathology , Paracrine Communication , Receptors, Neurokinin-1/metabolism , Receptors, Serotonin, 5-HT3/metabolism , Substance P/metabolism , Up-Regulation/physiology
11.
Planta Med ; 78(17): 1801-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23047250

ABSTRACT

Capsaicin and 6-gingerol, pungent components of chilli pepper and ginger, are known as dietary agonists of transient receptor potential vanilloid-1. Transient receptor potential vanilloid-1 nerve fibers are recognized to play a role in gastric mucosal integrity in rats. In the present studies, we examined the acute effects of peroral administration of capsaicin and 6-gingerol on gastric acid secretion in conscious mice. These agents were given p. o. 30 min before the pylorus was ligated. Oral administration of capsaicin (1.0-100 mg/kg) or 6-gingerol (1.5-50 mg/kg) significantly and dose-dependently inhibited basal acid secretion. Pretreatment with BCTC, a transient receptor potential vanilloid-1 antagonist, significantly reversed the reduced basal acid secretion by capsaicin or 6-gingerol. The combination of the lowest doses of capsaicin and 6-gingerol markedly inhibited basal acid secretion in conscious mice and this was also significantly reversed by BCTC. Moreover, the combination of the maximal dose of capsaicin and 6-gingerol inhibited basal acid secretion only to the level of a single administration of the maximal dose of capsaicin. These results suggest that the combination of capsaicin and 6-gingerol has an additive effect on the inhibition of gastric acid secretion through activation of transient receptor potential vanilloid-1. In separate experiments, intraduodenal administration of either capsaicin (30 mg/kg) or 6-gingerol (15 mg/kg), whose doses were observed to have a significant inhibitory effect by oral administration, tended to inhibit basal acid secretion compared with the vehicle. These results suggest that the combination of capsaicin and 6-gingerol has an additive effect on inhibition of gastric acid secretion through activation of transient receptor potential vanilloid-1, and oral administration of transient receptor potential vanilloid-1 agonists directly stimulates transient receptor potential vanilloid-1 in the gastric lumen, resulting in a potent reduction of gastric acid secretion.


Subject(s)
Capsaicin/pharmacology , Catechols/pharmacology , Fatty Alcohols/pharmacology , Gastric Acid/metabolism , TRPV Cation Channels/agonists , Administration, Oral , Animals , Capsaicin/administration & dosage , Capsicum/chemistry , Catechols/administration & dosage , Dose-Response Relationship, Drug , Drug Synergism , Drug Therapy, Combination , Fatty Alcohols/administration & dosage , Gastric Mucosa/drug effects , Zingiber officinale/chemistry , Male , Mice , Plant Extracts/pharmacology
12.
Lab Invest ; 92(5): 769-82, 2012 May.
Article in English | MEDLINE | ID: mdl-22330338

ABSTRACT

Abnormalities of primary afferent nerve fibers are strongly associated with the visceral hypersensitivity state in inflammatory bowel disease. Hypersensitivity of afferent fibers occurs during inflammation. Therefore, to gain an insight into the alterations to receptors and channels expressed in primary afferent neurons, the current study aimed to investigate the time-dependent dynamic changes in levels of 5-hydroxytryptamine (5-HT)(3) receptors, 5-HT(4) receptors, transient receptor potential vanilloid type 1 (TRPV1) channels, and 5-HT regulatory factors in dextran sulfate sodium (DSS)-induced colitis model mice. 5-HT signaling molecules were detected by indirect staining with specific antibodies. TRPV1-immunoreactivity was detected by staining with fluorescein-conjugated tyramide amplification. To assess nociception, visceromotor responses (VMRs) to colorectal distension were measured by electromyography of abdominal muscles. Immunohistochemical analysis and VMRs to colorectal distention were measured during induction of DSS colitis (days 4 and 7). Inflammation led to downregulation of serotonin transporter immunoreactivities with concomitant increases in 5-HT and tryptophan hydroxylase-1-positive cell numbers. TRPV1-expressing nerve fibers gradually increased during DSS treatment. Abundant nonneuronal TRPV1-immunopositive cell-like structures were observed on day 7 of DSS treatment but not on day 4. The number of 5-HT(3) receptor-expressing nerve fibers in the mucosa was increased on day 7. On the other hand, the number of 5-HT(4) receptor-expressing nerve fibers in the mucosa decreased on day 7. We made the novel observation of increased expression of neuronal/nonneuronal TRPV1 channels and 5-HT(3) receptors, and decreased expression of 5-HT(4) receptors in the mucosa in a DSS-induced colitis model. Visceral hyperalgesia was observed on day 7 but not on day 4. A TRPV1 antagonist and a 5-HT(3) receptor antagonist attenuated the visceral hyperalgesia to the control level. The alterations of 5-HT signaling via 5-HT(3) receptors and of TRPV1 channels in mucosa may contribute to the visceral hypersensitivity in colitis model mice.


Subject(s)
Hyperalgesia/physiopathology , Inflammatory Bowel Diseases/physiopathology , Receptors, Serotonin, 5-HT3/metabolism , Receptors, Serotonin, 5-HT4/metabolism , TRPV Cation Channels/metabolism , Visceral Afferents/physiopathology , Animals , Carbolines/pharmacology , Dextran Sulfate/administration & dosage , Dextran Sulfate/adverse effects , Disease Models, Animal , Electromyography , Hyperalgesia/metabolism , Inflammatory Bowel Diseases/chemically induced , Inflammatory Bowel Diseases/metabolism , Intestinal Mucosa/innervation , Intestinal Mucosa/metabolism , Male , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Nociception/drug effects , Pyrazines/pharmacology , Pyridines/pharmacology , Serotonin/metabolism , Serotonin Antagonists/pharmacology , TRPV Cation Channels/analysis , TRPV Cation Channels/antagonists & inhibitors , Time Factors , Tryptophan Hydroxylase/metabolism , Visceral Afferents/metabolism
13.
Pharmacol Res ; 65(2): 204-12, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21939768

ABSTRACT

Vasoactive intestinal peptide (VIP) regulates various functions including motility and immune homeostasis in colon. The VIP system including its receptors has been established to control the development of ulcerative colitis, but the functional changes of the system-regulated motility in colon with ulcerative colitis are not well understood. In this study, we investigated VIP-related contractile responses in distal colon from mice with dextran sulfate sodium (DSS)-induced acute colitis. Electrical stimulation (ES) under our conditions caused relaxation during ES and contraction after withdrawal of ES in a tetrodotoxin-sensitive manner. Pharmacological analyses showed two phases of ES-induced relaxation: a transient neuronal nitric oxide (NO) synthase-dependent phase (I), and a continued VIP receptor-mediated phase (II). Inhibition of VIP receptors and protein kinase A decreased both phases. In colon from DSS-treated mice, ES-induced phase II (also phase I) and VIP-induced, but not cyclic AMP analog-induced, relaxation were decreased. Stimulation with VIP significantly increased cyclic AMP formation in colon preparations from control but not DSS-treated mice. In colon from DSS-treated mice, the basal cyclic AMP level was markedly greater without changes in the level of VIP receptor VPAC(2). Isoprenaline- and forskolin-induced relaxation and cyclic AMP formation were not changed by DSS treatment. These findings suggest that dysfunction of VIP receptors in muscles, in addition to loss of the neuronal VIP and NO pathways, are involved in abnormal motility in mouse colon with DSS-induced colitis.


Subject(s)
Colitis/metabolism , Colitis/physiopathology , Muscle Relaxation/physiology , Vasoactive Intestinal Peptide/metabolism , Animals , Colitis/chemically induced , Colon/drug effects , Colon/metabolism , Colon/physiopathology , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Dextran Sulfate , Electric Stimulation , Mice , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Relaxation/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Muscle, Smooth/physiopathology , Nitric Oxide Synthase Type I/metabolism , Receptors, Vasoactive Intestinal Peptide/metabolism
14.
Naunyn Schmiedebergs Arch Pharmacol ; 385(1): 81-94, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21947227

ABSTRACT

Nitric oxide (NO) influences motility in the colon in patients with ulcerative colitis, but the exact mechanism involved remains unknown. Colitis was induced in mice by the oral administration of 2.5% dextran sodium sulfate (DSS), and the motility in longitudinal preparations from rectum and distal colon and expression of ß1 subunit of soluble guanylyl cyclase (sGCß1) were analyzed. Electrical stimulation (ES) caused a transient relaxation via the NO pathway in both rectum and colon from control mice. Stimulation with sodium nitroprusside (SNP) caused relaxation in the two regions, and the half-time (T (1/2)) of the maximal relaxation induced by 100 µM SNP was 8.1 ± 1.0 s in rectum. DSS treatment (1) abolished the ES-induced relaxation, but not dibutyryl cyclic GMP-induced response, in both regions, (2) decreased the maximal response to SNP accompanied by a loss of immunoreactive sGCß1 protein in rectum, but did not affect the amplitude of the relaxant response or the protein in distal colon, and (3) caused an increase in the T (1/2) value in response to SNP in both regions. Pretreatment of both preparations from control mice with 600 µM SNP for 30 min decreased both ES- and SNP-induced relaxation, SNP-induced cyclic GMP formation, and immunoreactive sGCß1 levels. NO-mediated relaxation was impaired by a dysfunctional sGC with and without a loss of immunoreactivity to sGCß1 in rectum and colon from DSS-treated mice, respectively. Long-term exposure of the tissues with an excess amount of NO changes the sGC-mediated relaxation.


Subject(s)
Colon/physiopathology , Guanylate Cyclase/physiology , Nitric Oxide/physiology , Receptors, Cytoplasmic and Nuclear/physiology , Rectum/physiopathology , Animals , Colitis/chemically induced , Colitis/physiopathology , Colon/drug effects , Colon/metabolism , Cyclic GMP/metabolism , Dextran Sulfate , Electric Stimulation , Male , Mice , Muscle Relaxation/drug effects , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Rectum/drug effects , Rectum/metabolism , Soluble Guanylyl Cyclase
15.
J Nat Med ; 65(1): 157-65, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21042867

ABSTRACT

Voacanga africana (Apocynaceae) is used as an anti-diarrheal medicine in West Africa. In the present study, we investigated the effect of an extract of V. africana and its constituents on smooth muscle contraction induced by capsaicin in mouse rectum, where transient receptor potential vanilloid type 1 (TRPV1)-immunoreactive fibers are abundant. Methanol and alkaloid extracts of the root bark of V. africana were found to inhibit capsaicin-induced contraction in a dose-dependent manner (30-300 µg/ml). Major constituents isolated from the alkaloid extract were then studied for their effects on the capsaicin-induced contraction. The main active constituents were found to be Iboga-type alkaloids, including voacangine (1), 3-oxovoacangine (2), voacristine (3), and (7α)-voacangine hydroxyindolenine (4). The voacangine concentration dependently (3-100 µM) inhibited the capsaicin-induced contraction. The capsaicin-induced contraction was almost completely inhibited by the TRPV1 antagonist, N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC). On the other hand, the Iboga-type alkaloids did not inhibit the contractions induced by 3 µM acetylcholine and 300 µM nicotine. These results suggest that Iboga-type alkaloids isolated from V. africana inhibit capsaicin-induced contraction in the mouse rectum, possibly via the inhibition of a TRPV1-mediated pathway. This inhibition may be involved in the anti-diarrheal effect of V. africana.


Subject(s)
Capsaicin/pharmacology , Indole Alkaloids/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Rectum/drug effects , Animals , Apocynaceae/chemistry , Immunohistochemistry , In Vitro Techniques , Indole Alkaloids/chemistry , Mice , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/metabolism
16.
Pharmacol Res ; 61(1): 48-57, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19744562

ABSTRACT

Recent reports suggest that cyclooxygenases (COXs) including COX-2 are constitutively expressed, and prostaglandins (PGs) regulate motility and/or contraction in the colon and rectum. This study examines the role of COXs in the regulation of neuromuscular function in longitudinal preparations of isolated rectum and distal colon (Side A, close to the transverse colon; and Side B, close to the rectum) in normal mice and after the induction of colitis by dextran sulfate sodium (DSS). In control rectum, electrical stimulation (ES)-induced contractions were inhibited by atropine and by COX inhibitors, in an independent manner. PGE(2) at 3microM caused a marked contraction, but the secondary response at 20min after the first application was 60% desensitized. In rectum from DSS-treated mice, spontaneous and ES-induced contractions were significantly less intense than in the control preparations, and the response to PGE(2) was abolished but that to 3microM acetylcholine was not. In control distal colon, the responses to PGE(2) in neither side were desensitized by the repeated application. In DSS-treated distal colon, PGE(2) response was impaired in the two regions, and was desensitized on Side B more than Side A. DSS treatment impaired contractions by 40mM KCl in rectum and on Side B but not Side A. DSS treatment increased COX-2 expression in rectum, but not in distal colon. These findings suggest that the induction of colitis by DSS affects ES- and PGE(2)-regulated motility in the order rectum>distal colon close to the rectum>distal colon in mice.


Subject(s)
Colitis/enzymology , Colon/enzymology , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Muscle Contraction , Rectum/enzymology , Acetylcholine/pharmacology , Animals , Colitis/chemically induced , Colitis/physiopathology , Colon/drug effects , Colon/innervation , Colon/physiopathology , Cyclooxygenase Inhibitors/pharmacology , Dextran Sulfate , Disease Models, Animal , Dose-Response Relationship, Drug , Electric Stimulation , Male , Mice , Muscle Contraction/drug effects , Rectum/drug effects , Rectum/innervation , Rectum/physiopathology , Time Factors
17.
Am J Physiol Gastrointest Liver Physiol ; 297(2): G348-60, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19497956

ABSTRACT

We investigated immunohistochemical differences in the distribution of TRPV1 channels and the contractile effects of capsaicin on smooth muscle in the mouse rectum and distal, transverse, and proximal colon. In the immunohistochemical study, TRPV1 immunoreactivity was found in the mucosa, submucosal, and muscle layers and myenteric plexus. Large numbers of TRPV1-immunoreactive axons were observed in the rectum and distal colon. In contrast, TRPV1-positive axons were sparsely distributed in the transverse and proximal colon. The density of TRPV1-immunoreactive axons in the rectum and distal colon was much higher than those in the transverse and proximal colon. Axons double labeled with TRPV1 and protein gene product (PGP) 9.5 were detected in the myenteric plexus, but PGP 9.5-immunoreactive cell bodies did not colocalize with TRPV1. In motor function studies, capsaicin induced a fast transient contraction, followed by a large long-lasting contraction in the rectum and distal colon, whereas in the transverse and proximal colon only the transient contraction was observed. The capsaicin-induced transient contraction from the proximal colon to the rectum was moderately inhibited by an NK1 or NK2 receptor antagonist. The capsaicin-induced long-lasting contraction in the rectum and distal colon was markedly inhibited by an NK2 antagonist, but not by an NK1 antagonist. The present results suggest that TRPV1 channels located on the rectum and distal colon play a major role in the motor function in the large intestine.


Subject(s)
Capsaicin/pharmacology , Colon/drug effects , Gastrointestinal Motility/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Myenteric Plexus/drug effects , Rectum/drug effects , TRPV Cation Channels/drug effects , Animals , Atropine/pharmacology , Colon/innervation , Colon/metabolism , Dose-Response Relationship, Drug , Immunohistochemistry , In Vitro Techniques , Male , Mice , Muscle, Smooth/innervation , Muscle, Smooth/metabolism , Myenteric Plexus/metabolism , Neurokinin A/metabolism , Pyrazines/pharmacology , Pyridines/pharmacology , Receptors, Neurokinin-1/drug effects , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-2/drug effects , Receptors, Neurokinin-2/metabolism , Rectum/innervation , Rectum/metabolism , Substance P/metabolism , TRPV Cation Channels/metabolism , Tetrodotoxin/pharmacology , Time Factors , Ubiquitin Thiolesterase/analysis
18.
Am J Physiol Gastrointest Liver Physiol ; 296(2): G319-29, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19023030

ABSTRACT

The physiology of gastric epithelial cells is often studied by using cancer cell lines, which may or may not provide information relevant to normal cells. Because few models exist to study chief cell physiology in vitro, our purpose was to develop primary cultured chief cells from rodent species that are structurally and functionally similar to native chief cells. For this, isolated chief cells from the rat stomach, purified by counterflow elutriation and density gradient centrifugation, were grown in media with growth factors. Purity and the continuity of tight junctions were determined, and permeability, viability, transepithelial resistance (TER), cell number and proliferation, and pepsinogen secretion in response to carbachol were measured. When plated in media alone or with basic fibroblast growth factor, the isolated chief cells attached by 2 days and were confluent by 4 days after seeding. However, tight junctions were discontinuous, TER was less than 300 Omega cm(2), and permeability was high. In contrast, chief cells incubated with hepatocyte growth factor (HGF) were confluent in 3 days and had a TER greater than 2,000 Omega cm(2), continuous tight junctions, and low permeability. EGF was intermediate. HGF facilitated monolayer development by increasing cell number, which occurred by the proliferation of chief cells. Chief cell cultures, grown with HGF, consisted of more than 99% gastric intrinsic factor-expressing cells and showed robust pepsinogen secretion. Coexpression studies for neck and chief cell markers suggest that the cultures are a mixture of mature, immature, and transitional zone cells. This model will be useful for investigating mechanisms that regulate chief cell physiology in health and disease.


Subject(s)
Cell Proliferation , Chief Cells, Gastric/metabolism , Hepatocyte Growth Factor/metabolism , Animals , Carbachol/pharmacology , Cell Adhesion , Cell Culture Techniques , Cell Differentiation , Cell Separation , Cell Survival , Cells, Cultured , Chief Cells, Gastric/drug effects , Chief Cells, Gastric/enzymology , Electric Impedance , Epidermal Growth Factor/metabolism , Fibroblast Growth Factor 2/metabolism , Humans , Pepsinogen A/metabolism , Permeability , Rats , Rats, Sprague-Dawley , Tight Junctions/metabolism , Time Factors
19.
Biol Pharm Bull ; 31(10): 1917-22, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18827355

ABSTRACT

Several methods are used to evaluate gastric motility in rodents, but they all have technical limitations. Recent technical developments enable a convenient method to evaluate gastric motility. The (13)C-acetic acid breath test in rodents is a non-invasive and repeatable method that can be used without physical restraints. The present study aimed to validate the (13)C-acetic acid breath test by measuring the effects of loperamide, morphine, mosapride, and itopride on gastric emptying in mice. Loperamide (1-10 mg/kg) and morphine (1.25-10 mg/kg) slowed gastric emptying and decreased the maximum concentration (C(max)) and area under the curve (AUC(90 min)) value in a dose-dependent manner. Mosapride (0.2-5 mg/kg) accelerated gastric emptying and increased C(max) value. Mosapride (20 mg/kg) did not accelerate gastric emptying on the (13)C-breath test. Itopride (30 mg/kg, per os) significantly accelerated gastric emptying compared with the vehicle group. In a comparison with the conventional phenol red test, there was a correlation between the C(max) value of breath test and gastric emptying (%) of phenol red tests in treatment with loperamide or mosapride. These results indicate that the (13)C-acetic acid breath test is an accurate, noninvasive, and simple method for monitoring gastric emptying in mice. This method is useful to assess the effect of drugs and gut function pharmacologically.


Subject(s)
Acetic Acid/analysis , Analgesics, Opioid/pharmacology , Anti-Ulcer Agents/pharmacology , Antidiarrheals/pharmacology , Antiemetics/pharmacology , Benzamides/pharmacology , Benzyl Compounds/pharmacology , Breath Tests/methods , Gastric Emptying/drug effects , Loperamide/pharmacology , Morphine/pharmacology , Morpholines/pharmacology , Animals , Coloring Agents , Male , Mice , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Phenolsulfonphthalein , Reproducibility of Results
20.
Lab Invest ; 88(11): 1227-44, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18779780

ABSTRACT

Corpus-predominant infection with Helicobacter pylori (HP) results in the activation of programmed cell death pathways in surface, parietal, and chief cells. At present, mechanisms that regulate these pathways to result in HP-associated pathology are not fully understood. Because it is not known which survival and death pathways are present in gastric epithelial cells, we used an antibody panel to evaluate the expression of BCL-2 family prosurvival proteins or multi-Bcl-2 homology (BH)-domains (group 1) or BH3-only (group-2) proapoptotic proteins in the stomachs of uninfected or HP-infected C57BL/6 mice. This strategy identified BCL-2, BAK, and BAD as the major prosurvival and proapoptotic proteins, in surface cells and BAD as the only BCL-2 family protein expressed in parietal cells. Chief cells express altogether different effectors, including BCL-X(L)/BCL-2, for survival but have no constitutively expressed proapoptotic proteins. In model chief cells, however, the group 1 proapoptotic protein BCL-X(S) was expressed after exposure to proinflammatory cytokines concomitant with reduced viability, demonstrating that chief cells can transcriptionally regulate the induction of proapoptotic proteins to execute apoptosis. During HP infection, no additional BCL-2 family proteins were expressed in epithelial cells, whereas those present either remained unchanged or were reduced as cell deletion occurred over time. Additional studies demonstrated that the posttranslational regulation of BAD in surface and parietal cells was negatively affected by HP infection, a result that may be directly related to an increase in apoptosis during infection. Thus, gastric epithelial cells express cell-specific prosurvival and proapoptotic pathways. From the results presented here, mechanisms that regulate HP-related changes in the survival and death profile of gastric epithelial cells can be predicted and then tested, with the ultimate goal of elucidating important therapeutic targets to inhibit the progression of HP-related pathology in the stomach.


Subject(s)
Apoptosis/physiology , Chief Cells, Gastric/metabolism , Helicobacter Infections/physiopathology , Helicobacter pylori , Parietal Cells, Gastric/metabolism , Stomach Diseases/physiopathology , Animals , Cells, Cultured , Disease Models, Animal , Female , Mice , Protein Processing, Post-Translational , Stomach Diseases/microbiology , bcl-Associated Death Protein/metabolism , bcl-X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...